 |
Macrogen Corp. (U.S.A)
Address : 9700 Great Seneca
Highway, Rockville, MD 20850
TEL: +1-301-251-1007
FAX
:+1-301-251-1007
|
|
| |
 |
Macrogen Corp. Japan
Address : Tokyo University of Agriculture, No.11 Building 3F.,
1-1-1 Sakuragaoka, Setagaya-Ku, Tokyo, 156-8502, Japan
TEL: +81-3-5799-4788
FAX
:+81-3-5799-4771
E-mail : customer@macrogen-japan.co.jp
Website : www.macrogen-japan.co.jp
|
|
| |
 |
Macrogen Corp. Europe
Address : IWO, Kamer IA3-195,
Meibergdreef 31
1105AZ Amsterdam The Netherlands
TEL: +31-(0)20-333-7563
E-mail : europe@macrogen.com
|
| |
|
| |
MACROGEN established a subsidiary company, MG MED, in 2001 to
provide medical services based on genetic
information. The specialty of Macrogen provides
hospitals and medical examination centers
with service in diagnosing
various contagious (infectious) disease,
HPV by using our own genetic
analysis technology.
In addition to diagnosing contagious(infectious) disease, MG
MED also provides services in diagnosing
chromosomal abnormalities using MACROGEN
BAC chips, approved by KFDAas IVD testal.
The company’s future vision is to expand
areas for genetic testing,for a variety
of purposes including drug sensitivity.
Such vision will help the
company to become the pioneer in both
disease diagnoses and prevention
by securing stable income structure.
|
| |
MGenbio is a venture corporation co-invested by MACROGEN and
Sunjin in 2002 to specialize organ
transplantation. Within a year after foundation,
the company succeeded in producing 'Hyeong-gwang-yi',
a pig cloned for transformation, thereby
establishing the area of cloning
and transforming technologies.
MGenbio is specialized for the development of bio-organs and
the production of the high-end protein products
for medical treatment. MGenbio, succeded
to produce human immune gene cloned pig
for anticancer treatment through augmenting
white blood cells. In June, 2006, the company
also merged with Sangsaengwon Inc., the
top goat milk producing company in Korea,
and development
of the bio-organs and protein medicines.
The company, established a firm and sound
foundation for success.
|
| |
 |
| |
Development |
1. Medical
treatment cells and tissues and heterogeneous organs |
2.
Protein medicine using nuclear transplant/transformation
technologies |
| 3. Business related
to disease treatment and prevention |
| 4.
Production of dewy goat milk |
| 5.
Diagnosis reagent and individual gene tracking business |
|
| |
 |
| Major Publication |
|
|
Production of nuclear transfer-derived
swine that express the enhanced green fluorescent
protein.
(Anim Biotech, (2001); 12:173-181.) |
|
Production of (1, 3) Galactosyltransferase
Knockout Pigs by Nuclear Transfer Cloning
(Science, (2002) ; 295:1089-1092) |
|
 |
|
|
| |
|
